Article
ADAM10 gene polymorphism and its relationship to hepatocellular carcinoma in Egyptian HCV patients receiving direct-acting antiviral therapies (DAAs)
2022-06-08
Abstract excerpt
<h4>Background: </h4> Hepatocellular carcinoma (HCC) is a multifactorial disease needs widened genetic studies. Taking in consideration the probable role of new direct-acting antiviral therapies (DAAs) of Hepatitis C infection (HCV) as predisposing factor of HCC as it provides longer lifetime for many late cirrhotic patients to develop hepatocellular carcinoma. Considering the reported potential biological roles o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cc5cc529-bb61-55d6-b962-51ca245da6b8
- DOI
- 10.21203/rs.3.rs-1701191/v1
